Home » Topics » Ocular, BioWorld Science

Ocular, BioWorld Science
RSS

Further approval for breakthrough glaucoma medication

Dec. 30, 1996

FDA ophthalmic devices committee meetings scheduled for January

Dec. 24, 1996

NIH offers anticataract invention for licensing

Dec. 20, 1996

DuPont Merck reports ester prodrugs for glaucoma

Dec. 19, 1996

VISX supplemental PMA slated for review

Dec. 12, 1996

InSite Vision completes preliminary clinical trial of ophthalmic drug candidate

Dec. 9, 1996

Neuregulin polypeptides described for treating retinal disorders

Nov. 26, 1996

Cambridge NeuroScience/Allergan ophthalmic disease collaboration

Nov. 26, 1996

P&U and PRIZM begin ophthalmological collaboration

Nov. 25, 1996

New market introduction for dorzolamide

Nov. 21, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
ASH 2025: Ianalumab data offer break from chronic ITP therapy
BioWorld
Novartis AG’s monoclonal antibody, ianalumab (VAY-736), when added to standard-of-care eltrombopag, extended disease control of primary immune thrombocytopenia...